High levels of urinary midkine in various cancer patients

被引:53
作者
Ikematsu, S
Okamoto, K
Yoshida, Y
Oda, M
Sugano-Nagano, H
Ashida, K
Kumai, H
Kadomatsu, K
Muramatsu, H
Muramatsu, T
Sakuma, S
机构
[1] Nagoya Univ, Grad Sch Med, Dept Biochem, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Meiji Dairies Corp, Kanagawa 2500862, Japan
[3] Univ Occupat & Environm Hlth, Dept Surg, Yahatanishi Ku, Kitakyushu, Fukuoka 8070804, Japan
[4] Kagoshima Univ, Fac Med, Sch Hlth Sci, Kagoshima 8908506, Japan
[5] Cell Signals Inc, Tsurumi Ku, Yokohama, Kanagawa 2300046, Japan
关键词
midkine; tumor marker; enzyme-linked immunoassay; urine;
D O I
10.1016/S0006-291X(03)00984-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Midkine (MK) is a heparin-binding growth factor, which promotes growth, migration, and survival of various cells, and MK expression is increased in many human carcinomas. We determined the urinary MK level by enzyme-linked immunoassay. Taking 311 pg/mg creatinine as a cut-off level, 70% of patients with various carcinomas (n = 142) gave positive values, while only 5.5% of healthy volunteers (n = 330) did. In case of gastric carcinoma, 17 out of 21 patients with stage I tumor were positive. Urinary MK levels are expected to become a convenient marker as an aid in detection of tumors. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:329 / 332
页数:4
相关论文
共 32 条
[1]
INCREASED MIDKINE GENE-EXPRESSION IN HUMAN GASTROINTESTINAL CANCERS [J].
ARIDOME, K ;
TSUTSUI, J ;
TAKAO, S ;
KADOMATSU, K ;
OZAWA, M ;
AIKOU, T ;
MURAMATSU, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (07) :655-661
[2]
Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status [J].
Costa, L ;
Demers, LM ;
Gouveia-Oliveira, A ;
Schaller, J ;
Costa, EB ;
de Moura, MC ;
Lipton, A .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :850-856
[3]
Francini G, 2001, CANCER, V92, P1468, DOI 10.1002/1097-0142(20010915)92:6<1468::AID-CNCR1471>3.0.CO
[4]
2-S
[5]
GARVER RI, 1994, CANCER, V74, P1584, DOI 10.1002/1097-0142(19940901)74:5<1584::AID-CNCR2820740514>3.0.CO
[6]
2-V
[7]
RECIPROCAL EXPRESSION OF PLEIOTROPHIN AND MIDKINE IN NORMAL VERSUS MALIGNANT LUNG TISSUES [J].
GARVER, RI ;
CHAN, CS ;
MILNER, PG .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1993, 9 (05) :463-466
[8]
Serum midkine levels are increased in patients with various types of carcinomas [J].
Ikematsu, S ;
Yano, A ;
Aridome, K ;
Kikuchi, M ;
Kumai, H ;
Nagano, H ;
Okamoto, K ;
Oda, M ;
Sakuma, S ;
Aikou, T ;
Muramatsu, H ;
Kadomatsu, K ;
Muramatsu, T .
BRITISH JOURNAL OF CANCER, 2000, 83 (06) :701-706
[9]
Solution structure of midkine, a new heparin-binding growth factor [J].
Iwasaki, W ;
Nagata, K ;
Hatanaka, H ;
Inui, T ;
Kimura, T ;
Muramatsu, T ;
Yoshida, K ;
Tasumi, M ;
Inagaki, F .
EMBO JOURNAL, 1997, 16 (23) :6936-6946
[10]
CDNA CLONING AND SEQUENCING OF A NEW GENE INTENSELY EXPRESSED IN EARLY DIFFERENTIATION STAGES OF EMBRYONAL CARCINOMA-CELLS AND IN MID-GESTATION PERIOD OF MOUSE EMBRYOGENESIS [J].
KADOMATSU, K ;
TOMOMURA, M ;
MURAMATSU, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 151 (03) :1312-1318